19th Jan 2010 12:02
RNS Number : 7802F
AGI Therapeutics plc
19 January 2010
AGI Therapeutics plc ("AGI" or the "Company")
Award of Options to Directors
On 18th January, 2010, AGI awarded the following options over ordinary shares of €0.01 each in the share capital of the Company ("Ordinary Shares") with an exercise price of €0.08 in accordance with the Company's share option scheme.
Director Number of options Resulting number
over Ordinary Shares of options held
granted
John Devane 1,260,000 3,290,160
Mary Martin 1,260,000 2,775,596
Patrick Ashe 840,000 2,355,596
David Kelly 840,000 2,355,596
Ends
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai